How many SC 13D/A filings has Serina Therapeutics, Inc. filed?

Serina Therapeutics, Inc. (SER) has 8 SC 13D/A (SC 13D/A) filings on record, spanning Jan 2024 to Dec 2024.

What is a SC 13D/A filing?

A SC 13D/A is an SEC filing known as "SC 13D/A." It is filed with the SEC as a SC 13D/A.

Where can I read Serina Therapeutics, Inc. SC 13D/A filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Serina Therapeutics, Inc. SC 13D/A filings, including risk assessment, sentiment analysis, and key financial figures.

Serina Therapeutics, Inc. (SER) — SC 13D/A Filings

All SC 13D/A filings from Serina Therapeutics, Inc.. Browse 8 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (8)

Juvenescence Ltd Amends Serina Therapeutics Stake — Dec 9, 2024 Risk: medium
Juvenescence Ltd, through its subsidiary JUVVENTURES (UK) LTD, has filed an amendment (Amendment No. 36) to its Schedule 13D concerning Serina Therapeutics, Inc
Juvenescence Ltd Files 13D/A Amendment for Serina Therapeutics — Jul 5, 2024 Risk: medium
Juvenescence Ltd, through its filing amendment 35 on July 5, 2024, reported a change in its beneficial ownership of Serina Therapeutics, Inc. The filing indicat
Juvenescence Ltd Amends AgeX Therapeutics Stake — Mar 26, 2024 Risk: medium
Juvenescence Ltd, through its filing on March 26, 2024, amended its Schedule 13D regarding AgeX Therapeutics, Inc. This amendment, the 34th, indicates a change
Juvenescence Ltd Amends AgeX Therapeutics Stake Filing — Mar 7, 2024 Risk: medium
Juvenescence Ltd, through its filing amendment dated March 7, 2024, has updated its Schedule 13D regarding AgeX Therapeutics, Inc. The filing indicates a change
Juvenescence Ltd Amends AgeX Therapeutics Ownership Filing — Feb 14, 2024 Risk: medium
Juvenescence Ltd filed an Amendment No. 32 to its Schedule 13D/A on February 14, 2024, regarding its beneficial ownership in AgeX Therapeutics, Inc. The filing
Juvenescence Ltd. Files 31st Amendment to AgeX Therapeutics Stake — Feb 5, 2024
Juvenescence Limited, a major shareholder in AgeX Therapeutics, Inc., filed an Amendment No. 31 to its Schedule 13D on February 1, 2024. This filing updates the
Juvenescence Amends AgeX Therapeutics Stake (Amendment No. 30) — Jan 17, 2024
Juvenescence Limited, a major shareholder in AgeX Therapeutics, Inc., filed an Amendment No. 30 to its Schedule 13D on January 16, 2024. This filing indicates a
Juvenescence Ltd. Amends AgeX Therapeutics Stake (Amendment 29) — Jan 9, 2024
Juvenescence Limited, a significant shareholder in AgeX Therapeutics, Inc., filed an Amendment No. 29 to its Schedule 13D on January 9, 2024, indicating a chang

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX